Stephen Gordon - 01 Apr 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon
Issuer symbol
TMDX
Transactions as of
01 Apr 2024
Net transactions value
-$533,250
Form type
4
Filing time
02 Apr 2024, 17:28:45 UTC
Previous filing
12 Mar 2024
Next filing
08 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $576,900 +15,000 +64% $38.46* 38,299 01 Apr 2024 Direct F1
transaction TMDX Common Stock Sale $1,110,150 -15,000 -39% $74.01 23,299 01 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -15,000 -29% $0.000000 37,477 01 Apr 2024 Common Stock 15,000 $38.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.